{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:35:13Z","timestamp":1790141713102,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Aminolevulinic acid (ALA) photodynamic therapy (PDT) is an established treatment option for actinic keratosis (AK), and recently fractional carbon dioxide (CO<jats:sub>2<\/jats:sub>) laser was shown to improve outcomes; but studies of short incubation photosensitizer are lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Assess the efficacy of short incubation ALA followed by blue light PDT with and without previous fractional CO<jats:sub>2<\/jats:sub> treatment for the treatment of AK.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Randomized, paired split-design, controlled trial of fractional CO<jats:sub>2<\/jats:sub> followed by ultrashort 15-minute versus 30-minute incubation ALA and blue light PDT for the treatment of AK on the face.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The complete clearance rates (CRs) at 8 weeks after ALA PDT with and without FxCO<jats:sub>2<\/jats:sub> at 30- and 15-minute ALA incubation times were 89.78% (+FxCO<jats:sub>2<\/jats:sub>) versus 71.20% CR (\u2212FxCO<jats:sub>2<\/jats:sub>) at 30\u2032, and 86.38% (+FxCO<jats:sub>2<\/jats:sub>) versus 69.23% (\u2212FxCO<jats:sub>2<\/jats:sub>) at 15\u2032 ALA incubation. All lesion improvements were statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>This randomized, comparative paired group controlled clinical study demonstrates that ultrashort 15- and 30-minute incubation ALA PDTs are of limited efficacy for the treatment of AK. Pretreatment with fractional ablative resurfacing yields statistically significant greater AK clearance with ALA-PDT at ultrashort ALA incubations followed by blue light.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000001117","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T17:05:00Z","timestamp":1491584700000},"page":"1053-1064","source":"Crossref","is-referenced-by-count":23,"title":["Randomized, Controlled Trial of Fractional Carbon Dioxide Laser Resurfacing Followed by Ultrashort Incubation Aminolevulinic Acid Blue Light Photodynamic Therapy for Actinic Keratosis"],"prefix":"10.1097","volume":"43","author":[{"given":"Macrene","family":"Alexiades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the veterans affairs topical tretinoin chemoprevention trial","volume":"116","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2001.114288","article-title":"Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light","volume":"45","author":"Jeffes","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.140.1.41","article-title":"Photodynamic therapy with aminolevulinic acid topical solution and visible blue, light in the treatment of multiple actinic keratoses of the face and scalp\u2014investigator-blinded, phase 3, multicenter trials","volume":"140","author":"Piacquadio","year":"2004","journal-title":"Arch Dermatol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminotaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"051607","DOI":"10.1117\/1.3484255","article-title":"Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate","volume":"15","author":"Warren","year":"2010","journal-title":"J Biomed Opt"},{"key":"R7-20230814","first-page":"629","article-title":"Short incubation PDT versus 5-FU in treating actinic keratoses","volume":"2","author":"Smith","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.140.1.33","article-title":"A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage","volume":"140","author":"Touma","year":"2004","journal-title":"Arch Dermatol"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/DSS.0000000000000630","article-title":"Randomized vehicle-controlled study of short drug incubation aminolevulinic acid photodynamic therapy for actinic keratoses of the face or scalp","volume":"42","author":"Pariser","year":"2016","journal-title":"Dermatol Surg"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000183753","article-title":"Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy","volume":"218","author":"Gerritsen","year":"2009","journal-title":"Dermatology"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/lsm.22259","article-title":"Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL)","volume":"46","author":"Haedersdal","year":"2014","journal-title":"Lasers Surg Med"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bjd.12507","article-title":"Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratosis and wart-like lesions in a randomized half-side comparative trial on dorsal hans","volume":"169","author":"Helsing","year":"2013","journal-title":"Br J Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jdv.12334","article-title":"Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study","volume":"28","author":"Ko","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/jdv.12953","article-title":"Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"29","author":"Choi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight mediated photodynamic therapy for actinic keratosis in organ transplant recipients\u2014a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5021\/ad.2013.25.4.417","article-title":"Photodynamic therapy with ablative carbon dioxide fractional laser in treatment of actinic keratosis","volume":"25","author":"Jang","year":"2013","journal-title":"Ann Dermatol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archderm.139.10.1313","article-title":"Laser-mediated photodynamic therapy of actinic keratoses","volume":"139","author":"Alexiades-Armenakas","year":"2003","journal-title":"Arch Dermatol"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00015550510032887","article-title":"A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (MetvixH)-PDT in actinic keratosis of the face and scalp","volume":"85","author":"Tarstedt","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1524-4725.2009.01096.x","article-title":"Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study","volume":"35","author":"Szeimies","year":"2009","journal-title":"Dermatol Surg"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2006.07470.x","article-title":"Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study","volume":"155","author":"Morton","year":"2006","journal-title":"Br J Dermatol"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1751-1097.1997.tb08581.x","article-title":"The role of subcellular localization in initiation of apoptosis by photodynamic therapy","volume":"65","author":"Kessel","year":"1997","journal-title":"Photochem Photobiol"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1142\/S1088424604000374","article-title":"Correlation between subcellular localization and photodynamic efficacy","volume":"8","author":"Kessel","year":"2004","journal-title":"J Porphyr Phthalocyanines"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.2910520318","article-title":"Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma","volume":"52","author":"Peng","year":"1992","journal-title":"Int J Cancer"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1994.244","article-title":"A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin","volume":"70","author":"Iinuma","year":"1994","journal-title":"Br J Cancer"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jphotobiol.2006.03.006","article-title":"Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines","volume":"84","author":"Ji","year":"2006","journal-title":"J Photochem Photobiol B"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1011-1344(96)07291-0","article-title":"An apoptotic response to photody- namic therapy with endogenous protoporphyrin in vivo","volume":"35","author":"Webber","year":"1996","journal-title":"J Photochem Photobiol B"},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"e50082","DOI":"10.1371\/journal.pone.0050082","article-title":"Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation","volume":"7","author":"Kobuchi","year":"2012","journal-title":"PLoS One"},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1039\/b611715e","article-title":"Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines","volume":"6","author":"Sailer","year":"2007","journal-title":"Photochem Photobiol Sci"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"Ratushny","year":"2012","journal-title":"J Clin Invest"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1562\/0031-8655(2002)076<0217:POPTIA>2.0.CO;2","article-title":"Promotion of photodynamic therapy-induced apoptosis by the mitochondrial protein Smacc\/DIABLO: dependence on Bax","volume":"76","author":"Usuda","year":"2002","journal-title":"Photochem Photobiol"},{"key":"R34-20230814","first-page":"3429","article-title":"Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection","volume":"59","author":"Kim","year":"1999","journal-title":"Cancer Res"},{"key":"R35-20230814","first-page":"663","article-title":"Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy","volume":"21","author":"Koukourakis","year":"2001","journal-title":"Anticancer Res"},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.2174\/092986711795843272","article-title":"Mechanisms of resistance to photodynamic therapy","volume":"18","author":"Casas","year":"2011","journal-title":"Curr Med Chem"},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/cancers3022516","article-title":"Cell death pathways in photodynamic therapy of cancer","volume":"3","author":"Mroz","year":"2011","journal-title":"Cancers"},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jcb.23400","article-title":"Links between mutant p53 and genomic instability","volume":"113","author":"Hanel","year":"2012","journal-title":"J Cell Biochem"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201708000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:06:20Z","timestamp":1692039980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201708000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001117","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}